6th Euro-Global Congress on Biotechnology & Bioengineering

The 6th Euro-Global Congress on Biotechnology & Bioengineering 2026 is an international platform uniting scientists, researchers, academicians, industry professionals, and policymakers to discuss transformative trends reshaping biotechnology and bioengineering.

This global gathering aims to explore innovations driving progress across genetic engineering, molecular biology, industrial biotechnology, bioprocess technology, synthetic biology, and bioinformatics. Participants will gain a deeper understanding of how biotechnology is revolutionizing healthcare, agriculture, environmental sustainability, and industrial production.

The congress will feature keynote lectures from world-renowned scientists, panel discussions on emerging technologies, interactive workshops, and poster sessions showcasing cutting-edge research. Attendees will also benefit from B2B networking sessions designed to foster collaborations between academia, research institutions, and the biotechnology industry.

Join us for two days of engaging discussions, scientific presentations, and global networking as we explore how bioengineering innovations are shaping a sustainable and technologically advanced future.

Market Analysis
The global biotechnology and bioengineering market continues to expand rapidly, driven by technological innovation, healthcare demand, and environmental challenges.
The global biotechnology market was valued at USD 1.55 trillion in 2024, projected to reach USD 3.9 trillion by 2032, growing at a CAGR of 12.5%.
Key drivers include the rising need for biopharmaceuticals, genetic testing, biofuels, and agricultural biotechnology.
The bioengineering sector, focusing on tissue engineering, biosensors, and computational biology, is witnessing record levels of R&D investment.
Europe remains a major hub for biotech research, supported by funding from the European Commission, Horizon Europe, and private venture capital firms.
Emerging markets in Asia-Pacific and Latin America are rapidly increasing their contributions through infrastructure expansion, bio-innovation clusters, and strategic partnerships.
Leading global companies such as Amgen, Genentech, Novozymes, Biocon, and Gilead Sciences are investing heavily in biomanufacturing, cell & gene therapy, and sustainable biotechnology solutions.
This congress will serve as a key meeting point for professionals seeking to understand market dynamics, investment trends, and policy frameworks shaping the biotechnology economy.

Why to Attend
Learn from Global Experts:
Hear from top scientists, researchers, and innovators presenting the latest breakthroughs in biotechnology and bioengineering.
Discover Emerging Technologies:
Explore cutting-edge trends in CRISPR gene editing, synthetic biology, bioinformatics, and industrial bioprocessing.
Present Your Research:
Share your findings through oral or poster presentations and receive global recognition from peers and industry leaders.
Build Collaborations:
Network with professionals from universities, biotech firms, research labs, and funding organizations worldwide.
Stay Ahead of Trends:
Understand global regulatory landscapes, intellectual property frameworks, and commercialization strategies.
Drive Innovation:
Be part of strategic discussions shaping the future of sustainable biotechnology, personalized medicine, and biomanufacturing.

Who Should Attend
The conference welcomes participants from diverse backgrounds in science, technology, and industry, including:
Biotechnologists & Bioengineers
Molecular Biologists & Geneticists
Pharmaceutical & Biopharma Professionals
Biomedical Scientists & Clinicians
Environmental & Agricultural Biotechnologists
Bioinformatics & Computational Biology Experts
Research Scholars, Professors & Students
Startups, Entrepreneurs & Investors in Biotech
Regulatory Experts & Policy Advisors
R&D Directors, Industry Leaders & Innovators

Benefits of Participation
Certification: Receive an internationally recognized Certificate of Participation or Presentation.
Publication Opportunities: Selected abstracts and papers will be published in indexed journals and digital conference proceedings.
Networking Access: Connect with 300+ international professionals from 40+ countries.
Global Exposure: Showcase your research, institution, or product to an elite scientific audience.
Collaboration Prospects: Explore partnerships with global biotech companies, investors, and universities.
Knowledge Enrichment: Gain insights into future technologies and market opportunities in biotechnology and bioengineering.
Career Growth: Enhance your academic and professional profile through meaningful engagement and exposure.